Bristol-Myers strengthens blood thinner warning
684132
Bristol-Myers Squibb  has  strengthened its warning about the risk of possible fatal  bleeding linked to its blood thinner drug, Coumadin, adding a  black box to its label, U.S. health officials said on Friday.
30572
After two highly publicized incidents questioning the safety of some of the biggest selling prescription medicines, the Food and Drug Administration said yesterday it is moving to strengthen its safety monitoring efforts.
430832
WASHINGTON  New warnings on anemia drugs  Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.
187963
Johnson & Johnson's Ortho Evra   contraceptive patch will come with a new warning about a study   suggesting users could face twice the risks of blood clots   compared with birth control pills, the company and U.S.   regulators said on Wednesday.
457534
Pfizer Inc. may strengthen the warning label for its painkiller Bextra to account for more information about a rare but serious skin reaction.
372735
Companies that make drugs to treat attention deficit hyperactivity disorder must take extra steps to alert patients to possible cardiovascular and psychiatric risks, U.S. health officials said on Wednesday.
695784
Pfizer Inc.'s Bextra will come with a new warning about possible heart and blood clotting problems when the drug is used by patients who have just had heart bypass surgery, the U.S. Food and Drug Administration said on Thursday.
290938
Boston Scientific Corp. BSX.N on   Thursday said an internal analysis confirmed an increased risk   of blood clots with its drug-coated device used to keep   previously clogged arteries open.
459566
LONDON/NEW YORK  - A court ruling upholding the patent on blockbuster blood-thinning drug Plavix has reignited talk France's Sanofi-Aventis  will bid for its smaller U.S. partner Bristol-Myers Squibb Co. .
108049
WASHINGTON -- The Food and Drug Administration warned consumers yesterday not to buy or use the supplements Actra-Rx or Yilishen because they contain an ingredient that could lower blood pressure to unsafe levels.
586119
The FDA has just changed the warning label on the pain reliever Bextra to emphasize the risk of a rare but potentially fatal &quot;skin reaction,&quot; Stevens-Johnson syndrome.
160874
The maker of a controversial pill used after sexual intercourse to prevent pregnancy - and linked to the death of a California teenager - is adding a new warning to the pill label indicating it can lead to serious bacterial infections.
617859
Eli Lilly and Co. said Friday it added a warning to the label of its attention deficit/hyperactivity disorder medicine, advising patients with jaundice or a liver injury to stop taking the treatment.
678814
Anemia drugs sold by Amgen Inc. and Johnson & Johnson will carry a new boxed warning advising doctors to choose the lowest dose needed to avoid blood transfusions, the U.S. Food and Drug Administration said on Friday.
186256
Labels that warn about potential suicide risks for young patients taking antidepressants need to be stronger. That&#39;s the word from a Food and Drug Administration advisory panel Tuesday.
728273
Although a U.S. judge has halted  continued shipments of a generic form of Bristol-Myers Squibb  Co.'s  best-selling drug, analysts on Friday cautioned  that huge supplies already on the market would hurt the  company's earnings in 2006 and 2007.
33587
Amgen Inc. and Johnson & Johnson anemia drugs will carry strong new warnings after studies showed a higher risk of death and life-threatening side effects in some patients, U.S. health officials said on Friday.